Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
24 studies found for:    " January 04, 2012":" February 03, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Download search resultsDownload the search results for:
" January 04, 2012":" February 03, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION] (24 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Recruiting Short Term Intensified Chemo-immunotherapy in HIV-positive Patients With Burkitt Lymphoma
Conditions: HIV;   Burkitt's Lymphoma
Interventions: Drug: Induction Phase;   Drug: Consolidation Phase (on day +50);   Drug: Intensification phase;   Drug: BEAM conditioning;   Radiation: Consolidation radiotherapy
2 Completed Open-Label Pilot Study to Evaluate Switching From a Regimen Consisting of Raltegravir Plus Emtricitabine/Tenofovir DF Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infections
Intervention: Drug: EVG/COBI/FTC/TDF
3 Completed Leptin for Abnormal Lipid Kinetics in HIV Lipodystrophy Syndrome
Condition: HIV Lipodystrophy
Interventions: Drug: Human recombinant leptin ("metreleptin");   Drug: Placebo
4 Unknown  Development of Method of Fructose Identification in Urine to Detect the Viral Infection
Condition: Human Immunodeficiency Virus
Intervention:
5 Active, not recruiting Perinatal Antiretroviral Intensification for PMTCT of HIV in Late Comers
Condition: HIV Infections
Intervention: Drug: Nevirapine, zidovudine, lamivudine
6 Completed Use of Incentives to Engage Drug Users in HIV Therapy
Condition: HIV Infection
Intervention: Other: monetary reinforcer
7 Completed A Phase Il of a Therapeutic, Recombinant, Biologically Active HIV-1 Tat Protein Vaccine in HIV-Infected, Anti-Tat Negative, ARV-Treated Adult Volunteers
Condition: HIV Infections
Interventions: Biological: Tat;   Biological: Placebo
8 Recruiting Evaluating the Safety and Tolerability of Antiretroviral Drug Regimens Used as Pre-Exposure Prophylaxis to Prevent HIV Infection in At-Risk Men Who Have Sex With Men and in At-Risk Women
Condition: HIV Infection
Interventions: Drug: Maraviroc;   Drug: Emtricitabine;   Drug: Tenofovir disoproxil fumarate;   Other: Maraviroc placebo;   Other: Emtricitabine placebo;   Other: Tenofovir disoproxil fumarate placebo
9 Completed Observational Study of Nevirapine Extended Release in Human Immunodeficiency Virus (HIV) Patients in Daily Clinical Practice
Condition: HIV Infections
Intervention:
10 Completed An Efficacy and Safety Study of Telaprevir in Patients Infected With Both Chronic Hepatitis C Virus (HCV-1) and Human Immunodeficiency Virus (HIV-1)
Condition: Chronic Hepatitis C
Interventions: Drug: Telaprevir;   Drug: Ribavirin;   Drug: Pegylated-Interferon-alfa-2a
11 Recruiting Inflammation, Viral Replication, and Atherosclerosis in Treated HIV Infection
Condition: Atherosclerosis
Intervention:
12 Unknown  Randomized Controlled Trial Using Patient Reported Outcomes and Care Managers to Improve HIV Medication Adherence in Routine Clinical Care
Condition: HIV
Intervention: Behavioral: Care management
13 Not yet recruiting Repeat Sexually Transmitted Infection (STI) Patients: Tailored Socio-Contextual Intervention to Reduce HIV Risk
Conditions: Sexually Transmitted Infection;   HIV
Interventions: Behavioral: Tailored Socio-Contextual Intervention;   Behavioral: Standard of Care
14 Completed Evaluation of the MBio Combined Syphilis/HIV Point-of-Care Diagnostic Test
Conditions: HIV;   Syphilis
Intervention: Device: MBIO POC combined HIV syphilis test ( SnapEsi)
15 Recruiting Vitamin D Supplementation in HIV Youth
Condition: HIV+
Intervention: Drug: Vitamin D3
16 Unknown  Long Term Immunogenicity of Quadrivalent Human Papillomavirus Vaccine (Gardasil®)in HIV-infected Adolescents and Young Adults
Conditions: HPV;   HIV
Intervention: Biological: Quadrivalent Human Papillomavirus (6, 11, 16 and 18) vaccine (Gardasil ®)
17 Active, not recruiting
Has Results
Efficacy of Atazanavir/Ritonavir Monotherapy as Maintenance in Patients With Viral Suppression
Condition: HIV-1 Infection
Intervention: Drug: Atazanavir/ritonavir monotherapy
18 Completed EuroNeut41: Safety & Immunogenicity of Immunisations With HIV Vaccine
Condition: HIV
Interventions: Biological: EN41-FPA2 HIV vaccine;   Biological: Na Cl Placebo vaccine
19 Unknown  Rapid Oral Test for Therapeutic Response in HIV/AIDS Patients
Condition: AIDS/HIV PROBLEM
Intervention:
20 Completed Men Who Have Sex With Men (MSM) Neurocog 1&2 Study
Condition: HIV Related Neurocognitive Impairment
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-24) Show next page of results    Last Page
Indicates status has not been verified in more than two years